Solid Biosciences Inc.
Most Recent
Company & Industry OverviewsWhy Solid Biosciences Stock Nosedived 67.82% Yesterday
On February 7, Solid Biosciences (SLDB) closed at $7.19, 67.82% lower than its previous closing price.
Company & Industry OverviewsSolid Biosciences and Its Focus on Duchenne Muscular Dystrophy
In the fourth quarter of 2017, Solid Biosciences initiated a Phase 1/2 clinical trial called IGNITE DMD to test SGT-001 in the United States.
Company & Industry OverviewsBioMarin Pharmaceutical and Its Promising Research Pipeline
Stocks focused on gene therapy have garnered strong investor interest in 2018. In this series, we’ll analyze four of those companies.
Company & Industry OverviewsWhy resTORbio Stock Is Seeing Solid Growth Today
Today, resTORbio (TORC) is trading at $13.36, which represents 48.28% growth from yesterday when it was trading at $9.01.